Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-061005
Filing Date
2008-11-04
Accepted
2008-11-04 16:37:23
Documents
1
Period of Report
2005-08-01

Document Format Files

Seq Description Document Type Size
1 v130464_ex.html 3  
1 v130464_ex.xml 3 7819
  Complete submission text file 0001144204-08-061005.txt   9637
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XTL BIOPHARMACEUTICALS LTD 711 EXECUTIVE BLVD., SUITE Q VALLEY COTTAGE NY 10989
Business Address (845) 267-0707
KENNEDY WILLIAM JAMES (Reporting) CIK: 0001448888 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 081161276